{
  "chunk_id": "V_iii_5_None_15",
  "content": "/>\nIntroduction\nThis topic contains information about applying the evaluation criteria for diseases of the heart, including\nevaluating heart disease using metabolic equivalents (METs)\nimpact of non-service-connected (NSC) conditions on the evaluation of METs\naspirin as continuous medication\nevaluation of nephritis and cardiovascular disabilities\nevaluating arrhythmias\n, and\nconsidering co-existing heart conditions and arrhythmia\n.",
  "title": "M21-1, Part V, Subpart iii, Chapter 5 - Cardiovascular System Conditions",
  "citation": "Part V, Subpart iii, Chapter 5, Section None",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014520/M21-1-Part-V-Subpart-iii-Chapter-5-Cardiovascular-System-Conditions",
  "updated": "",
  "scraped_at": "2025-06-16T22:44:48.867451",
  "tags": [
    "m21-1"
  ]
}